INCRUSE ELLIPTA is a prescription medication used in the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It contains the active ingredient umeclidinium, which is a long-acting muscarinic antagonist (LAMA). This type of medication works by relaxing the muscles around the airways in the lungs, helping to keep the airways open and making it easier to breathe. INCRUSE ELLIPTA is administered through inhalation using a specific Ellipta inhaler device, designed for ease of use. It is typically prescribed as a once-daily treatment, contributing to the long-term management of COPD symptoms but is not intended for the relief of acute bronchospasm or as a rescue therapy.